Skip to content

Investigating the effect of virtual group therapy based on emotion regulation on quality of life and life expectancy in the women with breast cancer

Investigating the effect of virtual group therapy based on emotion regulation on quality of life and life expectancy in the women with breast cancer

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231019059769N3
Enrollment
96
Registered
2025-01-26
Start date
2024-11-26
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer. Benign neoplasm of breast

Interventions

Intervention 1: Both the intervention and control groups will receive first-line therapeutic interventions. The intervention group will receive group therapy interventions in addition to routine treat

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ability to read and write Not using drugs according to self-reported information Willingness to participate in the study No history of hospitalization in neurology hospitals Not experiencing the loss of loved ones in the last six months No experience of divorce in the last six months Awareness and awareness of the disease

Exclusion criteria

Exclusion criteria: Unwillingness to continue cooperation Not participating in more than two intervention sessions Acute disease conditions and chemotherapy Participants in educational programs or psychological interventions In case of drug use in the middle of the intervention

Design outcomes

Primary

MeasureTime frame
Increasing quality of life and life expectancy. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Miller's life expectancy questionnaire and Weber and Sherburne's quality of life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahnaz Rakhshan

Shiraz University of Medical Sciences

rakhshanm@sums.ac.ir+98 917 313 4261

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026